Real-world effectiveness of early remdesivir in reducing mortality among vulnerable patients hospitalized for COVID-19: Evidence for clinical pharmacists and inpatient care providers
Remdesivir Shows Promise in Reducing COVID-19 Mortality: What Does the Future Hold? Recent research continues to bolster the case for remdesivir as a valuable tool in combating severe COVID-19, particularly among vulnerable patient populations. A retrospective study analyzing data from December 2021 to December 2024, encompassing over 220,000 hospitalized patients, revealed a significant reduction in … Read more